Radiology AI Directory

FDA-cleared profile

Precise Position

Philips Healthcare (Suzhou) Co., Ltd.

Precise Position uses a ceiling-mounted color and depth camera with a convolutional neural network to identify orientation, recommend surview range, and center head, chest, abdominal, or pelvic anatomy before CT.

CT/CTA workflow
Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.

Clinical details

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Precise Position uses a ceiling-mounted color and depth camera with a convolutional neural network to identify orientation, recommend surview range, and center head, chest, abdominal, or pelvic anatomy before CT.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
Qualified CT technologists and trained Incisive CT operators.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Care setting and population
Hospitals, outpatient clinics, research institutions, and other clinical facilities using supported Philips Incisive CT systems.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Workflow role
Camera-assisted patient orientation, centering, and scan-range setup before CT localization and acquisition.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Required input
Color and depth images of a patient positioned on the CT table.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Output and human action
Patient orientation, recommended surview start and end positions, anatomy centering, and visual camera images.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Limitations
Patients younger than 16 years and decubitus orientations are unsupported. Results can be affected by coverings, incomplete camera view, reflective, black, or thick clothing, and other people near the table; manual positioning remains available.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K203514
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2021-06-17
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
Ceiling camera, gantry power, high-speed cable, Incisive CT console, and positioning controls; validate room geometry, field of view, table coordinates, manual override, patient privacy, and failure behavior.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Deployment and data flow
Optional ceiling-mounted color and depth camera plus software integrated with Philips Incisive CT.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Security and privacy
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-03

Public materials reviewed for this batch do not establish the complete security posture for the exact release. Request data-flow, identity, audit, encryption, retention, support-access, vulnerability-management, backup, and incident-response evidence.

Training and support
Only qualified ct technologists and trained incisive ct operators. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring and change control
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Patients younger than 16 years and decubitus orientations are unsupported. Results can be affected by coverings, incomplete camera view, reflective, black, or thick clothing, and other people near the table; manual positioning remains available.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K203514 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Source

Interoperability acceptance

Ceiling camera, gantry power, high-speed cable, Incisive CT console, and positioning controls; validate room geometry, field of view, table coordinates, manual override, patient privacy, and failure behavior.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

SourceSource

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Patients younger than 16 years and decubitus orientations are unsupported. Results can be affected by coverings, incomplete camera view, reflective, black, or thick clothing, and other people near the table; manual positioning remains available.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Source

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Source

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Patients younger than 16 years and decubitus orientations are unsupported. Results can be affected by coverings, incomplete camera view, reflective, black, or thick clothing, and other people near the table; manual positioning remains available.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

SourceSource

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K203514 reports an 80-position clinical evaluation, split 40 with and 40 without Precise Position, by five clinical experts. The study reported up to 23% shorter positioning time, 50% greater vertical-position accuracy, and 70% greater vertical and horizontal consistency.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

Positioning sessions

80 sessions

  • EndpointPrecise Position versus manual workflow
  • PopulationPrecise Position
  • Tested versionPrecise Position cleared in K203514 for Philips Incisive CT
Source

Positioning time reduction

23 %

  • EndpointTime from patient selection to scan-ready command
  • PopulationPrecise Position
  • Tested versionPrecise Position cleared in K203514 for Philips Incisive CT
Source

Vertical-position accuracy increase

50 %

  • EndpointVertical isocenter accuracy
  • PopulationPrecise Position
  • Tested versionPrecise Position cleared in K203514 for Philips Incisive CT
Source

Position consistency increase

70 %

  • EndpointVertical and horizontal positioning consistency
  • PopulationPrecise Position
  • Tested versionPrecise Position cleared in K203514 for Philips Incisive CT
Source

K203514 FDA performance package for Precise Position

  • DesignManufacturer controlled clinical workflow evaluation comparing camera-assisted and manual positioning
  • Population80 CT positioning sessions evaluated by five clinical experts
  • Scopeexact submission
  • Tested versionPrecise Position cleared in K203514 for Philips Incisive CT
  • Samplen=80
  • IndependenceSponsor or vendor study

K203514

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

Source

Costs and setup

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-03

No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

Reimbursement and coding
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Public source
  • Not applicable
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

Source

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K203514 by exact submission identifier.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03

A zero-result exact-identifier search does not prove that no recall, correction, adverse-event report, or product-family safety signal exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
24Fields reviewed
8Source classes checked
20Awaiting review PubMed leads
4Awaiting review trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA materials, current product-family sources, selected clinical literature, reimbursement context, and exact-identifier recall candidates were reviewed. Pricing, contracted services, enabled options, final security architecture, and local interoperability remain organization-specific evidence. Automated exact-name discovery found 20 PubMed and 4 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Sources & history

How this profile was documented

Open the ledger for source dates, scope, and research-record updates.

View source ledger and history

Source ledger

  1. K203514 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Philips CT Smart Workflow

    Philips - Accessed 2026-09-03

    Scope: productFamily, workflowRole, implementationCapabilities, currentCommercialContext

Research history

  1. K203514 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

Alternatives

Related tools to compare

FDA-cleared K253649

Spectral CT Verida Family

Philips Medical Systems Technologies, Ltd.

Spectral CT Verida Family supports the labeled spectral CT acquisition, reconstruction, material-map, and professional-interpretation workflow; exact models, protocols, and...

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-27
CT/CTA workflow
FDA-cleared K253574

SOMATOM X.cite; SOMATOM X.ceed

Siemens Medical Solutions USA, Inc.

SOMATOM X.cite and X.ceed with syngo CT VB20 support diagnostic CT, interventions, treatment preparation, radiation-therapy planning, and qualified low-dose lung screening.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-20
CT/CTA workflow
FDA-cleared K232491

CT 5300

Philips Healthcare (Suzhou) Co., Ltd.

CT 5300 acquires head and whole-body cross-sectional CT images for diagnosis in adult and pediatric patients and supports low-dose lung-cancer screening under approved protocols.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2024-05-03
CT/CTA workflow